Olanzapine in the Treatment of Patients With Anorexia Nervosa

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

July 31, 2006

Study Completion Date

September 30, 2006

Conditions
Anorexia Nervosa
Interventions
DRUG

Olanzapine

After a 2-week baseline period, olanzapine was administered for 10 weeks (weeks 3-12 of the study). Olanzapine was prescribed according to a flexible dose regimen, starting at the minimum dose of at 2.5 mg/day and titrated slowly by increments of 2.5 mg/week to a maximum dose of of 10 mg/day.

BEHAVIORAL

Day Hospital

Day hospital program involved attendance 4 days a week from 9:00 am to 6:00 pm for 12 to 14 weeks, and supervised meals and group therapy.

Trial Locations (1)

K1Y 4E9

Ottawa Hospital, Ottawa

All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER

collaborator

Eli Lilly and Company

INDUSTRY